General Information of the Compound
Compound ID |
CP0057024
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
med.21724, Compound Gemcitabine
Show/Hide
|
||||||||||||||||||
Synonyms |
DDFC
DFdC
DFdCyd
Folfugem
GEO
Gamcitabine
GemLip
Gemcel
Gemcin
Gemcitabina
Gemcitabina [INN-Spanish]
Gemcitabine
Gemcitabine (USAN/INN)
Gemcitabine HCl
Gemcitabine hydrochloride
Gemcitabine stereoisomer
Gemcitabinum
Gemcitabinum [INN-Latin]
Gemtro
Gemzar
Gemzar (TN)
Gemzar (hydrochloride)
Inno-D07001
LY 188011
LY-188011
LY188011
Zefei
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C9H11F2N3O4
|
||||||||||||||||||
Molecular Weight |
263.2
|
||||||||||||||||||
Canonical SMILES |
Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C9H11F2N3O4/c10-9(11)6(16)4(3-15)18-7(9)14-2-1-5(12)13-8(14)17/h1-2,4,6-7,15-16H,3H2,(H2,12,13,17)/t4-,6-,7-/m1/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
SDUQYLNIPVEERB-QPPQHZFASA-N
|
||||||||||||||||||
CAS |
95058-81-4
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01831, Deoxycytidine kinase
Protein ID: PT04241, Equilibrative nucleoside transporter 1
Clinical Information about the Compound
Drug 1 ( Gemcitabine )
Drug Name | Gemcitabine | ||
---|---|---|---|
Company | Eli Lilly | ||
Indication | |||
Target(s) |